About Chitotriosidase-1
Chitotriosidase-1 (CHIT1) is a protein
from Homo sapiens identified by UniProt accession
Q13231, 466 residues long.
MolForge cross-references it against 0 known binders and
325 disease associations.
Target properties
| Protein name | Chitotriosidase-1 |
| UniProt accession | Q13231 |
| Gene | CHIT1 |
| Organism | Homo sapiens |
| Length | 466 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (325)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.43
- YKL40 measurement · score 0.36
- mean reticulocyte volume · score 0.29
- chitotriosidase-1 measurement · score 0.25
- cerebrospinal fluid biomarker measurement · score 0.22
- high density lipoprotein cholesterol measurement · score 0.21
- chitotriosidase deficiency · score 0.21
- neurodegenerative disease · score 0.20
- reticulocyte count · score 0.15
- sarcoidosis · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q13231-F1 | alphafold | PREDICTED | 91.42 | — |
Amino-acid sequence (466 residues)
MVRSVAWAGF MVLLMIPWGS AAKLVCYFTN WAQYRQGEAR FLPKDLDPSL CTHLIYAFAG MTNHQLSTTE WNDETLYQEF NGLKKMNPKL KTLLAIGGWN FGTQKFTDMV ATANNRQTFV NSAIRFLRKY SFDGLDLDWE YPGSQGSPAV DKERFTTLVQ DLANAFQQEA QTSGKERLLL SAAVPAGQTY VDAGYEVDKI AQNLDFVNLM AYDFHGSWEK VTGHNSPLYK RQEESGAAAS LNVDAAVQQW LQKGTPASKL ILGMPTYGRS FTLASSSDTR VGAPATGSGT PGPFTKEGGM LAYYEVCSWK GATKQRIQDQ KVPYIFRDNQ WVGFDDVESF KTKVSYLKQK GLGGAMVWAL DLDDFAGFSC NQGRYPLIQT LRQELSLPYL PSGTPELEVP KPGQPSEPEH GPSPGQDTFC QGKADGLYPN PRERSSFYSC AAGRLFQQSC PTGLVFSNSC KCCTWN
Explore Chitotriosidase-1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets